Anne-Sophie Mariet1,2,3,4, Eric Benzenine1,2,3,4, Benjamin Bouillet5,6, Bruno Vergès5,6, Catherine Quantin1,2,3,4, Jean-Michel Petit5,6. 1. Biostatistics and Bioinformatics (DIM), Dijon University Hospital, Dijon, France. 2. University of Burgundy and Franche-Comte, Dijon, France. 3. INSERM, CIC 1432, Dijon, France. 4. Clinical Investigation Center, Clinical Epidemiology/Clinical Trials Unit, Dijon University Hospital, Dijon, France. 5. INSERM Unit, LNC-UMR 1231, University of Burgundy, Dijon, France. 6. Department of Endocrinology, Diabetes and Metabolic Disorders, Dijon University Hospital, Dijon, France.
Abstract
AIMS/HYPOTHESIS: The aim of this study was to examine the impact of the COVID-19 epidemic on the hospitalization rates for diabetic foot ulcer (DFU), osteomyelitis and lower limb revascularization procedure in people with DFU. METHODS: This nationwide retrospective cohort study included hospital data on all people hospitalized in France for diabetes in weeks 2-43 in 2020, including the COVID-19 lockdown period, compared to same period in 2019. RESULTS: The number of hospitalizations for DFU decreased significantly in weeks 12-19 (during the lockdown) (p < 10-4 ). Hospitalization for foot osteomyelitis also decreased significantly in weeks 12-19 (p < 10-4 ). The trend was the same for lower limb amputations and revascularizations associated with DFU or amputation. CONCLUSIONS/ INTERPRETATION: The marked drop in hospitalization rates for DFU, osteomyelitis and lower limb revascularization procedures in people with DFU observed in France during the lockdown period suggests that COVID-19 was a barrier to DFU care, and may illustrate the combined deleterious effects of hospital overload and changes in health-related behaviour.
AIMS/HYPOTHESIS: The aim of this study was to examine the impact of the COVID-19 epidemic on the hospitalization rates for diabetic foot ulcer (DFU), osteomyelitis and lower limb revascularization procedure in people with DFU. METHODS: This nationwide retrospective cohort study included hospital data on all people hospitalized in France for diabetes in weeks 2-43 in 2020, including the COVID-19 lockdown period, compared to same period in 2019. RESULTS: The number of hospitalizations for DFU decreased significantly in weeks 12-19 (during the lockdown) (p < 10-4 ). Hospitalization for foot osteomyelitis also decreased significantly in weeks 12-19 (p < 10-4 ). The trend was the same for lower limb amputations and revascularizations associated with DFU or amputation. CONCLUSIONS/ INTERPRETATION: The marked drop in hospitalization rates for DFU, osteomyelitis and lower limb revascularization procedures in people with DFU observed in France during the lockdown period suggests that COVID-19 was a barrier to DFU care, and may illustrate the combined deleterious effects of hospital overload and changes in health-related behaviour.
Authors: Maria Narres; Heiner Claessen; Tatjana Kvitkina; Joachim Rosenbauer; Maria Scheider; Stephan Morbach; Andrea Icks Journal: Eur J Epidemiol Date: 2022-06-08 Impact factor: 12.434
Authors: Charles de Mestral; David Gomez; Andrew S Wilton; Douglas S Lee; Zaina Albalawi; Peter C Austin; Jean Jacob-Brassard; David R Urbach; Mohammed Al-Omran; Nancy N Baxter Journal: JAMA Netw Open Date: 2022-01-04
Authors: Marcin Kleibert; Beata Mrozikiewicz-Rakowska; Patrycja Małgorzata Bąk; Daniel Bałut; Jakub Zieliński; Leszek Czupryniak Journal: Int J Environ Res Public Health Date: 2022-03-23 Impact factor: 3.390